Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 色谱法 化学
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
申陌发布了新的文献求助10
1秒前
研友_VZG7GZ应助常常采纳,获得10
1秒前
小鱼完成签到,获得积分10
2秒前
拾陆发布了新的文献求助10
2秒前
TATA发布了新的文献求助10
2秒前
小徐801完成签到,获得积分10
2秒前
3秒前
3秒前
3秒前
cloud完成签到 ,获得积分10
3秒前
luria发布了新的文献求助10
3秒前
4秒前
Eliauk完成签到,获得积分10
4秒前
MJ完成签到 ,获得积分10
4秒前
4秒前
swnucquwd发布了新的文献求助10
4秒前
5秒前
比格蹦蹦完成签到,获得积分10
5秒前
无限安荷发布了新的文献求助10
5秒前
夏木发布了新的文献求助10
5秒前
镜花水月完成签到,获得积分10
5秒前
重逢完成签到,获得积分10
5秒前
天天快乐应助EmocrazyT采纳,获得10
6秒前
JamesPei应助土豆采纳,获得10
7秒前
走四方发布了新的文献求助10
7秒前
MJ关注了科研通微信公众号
7秒前
何书易完成签到,获得积分10
7秒前
8秒前
香瓜完成签到,获得积分20
8秒前
jmk发布了新的文献求助10
8秒前
852应助TATA采纳,获得10
9秒前
2233完成签到,获得积分10
9秒前
zk1438328200完成签到,获得积分10
9秒前
lkl发布了新的文献求助10
9秒前
念兮完成签到,获得积分10
9秒前
9秒前
9秒前
英姑应助木木三采纳,获得10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Introduction to Helicopter and Tiltrotor Flight Simulation, Second Edition 2500
卤化钙钛矿人工突触的研究 2000
Malcolm Fraser : a biography 700
Signals, Systems, and Signal Processing 610
Software that combines deep learning,3D reconstruction and CFD to analyze the state of carotid arteries from ultrasound imaging 600
Bounds for Statistical Estimation in Semiparametric Models 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6498994
求助须知:如何正确求助?哪些是违规求助? 8294713
关于积分的说明 17699974
捐赠科研通 5595283
什么是DOI,文献DOI怎么找? 2917814
邀请新用户注册赠送积分活动 1894905
关于科研通互助平台的介绍 1755642